SCHEMBL25570912

SCHEMBL25570912

Cc1ccccc1-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cncc(-c5cccc(-c6ccccc6)c5)c34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VSIR Q9H7M9 1/20 0.36
PTPN1 P18031 1/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
TRPA1 O75762 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
NPC1 O15118 4/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAP3K8 P41279 3/20 0.33
CYP17A1 P05093 2/20 0.33
CYP1A2 P05177 2/20 0.33
LCK P06239 1/20 0.33
KDR P35968 1/20 0.33
JAK3 P52333 1/20 0.33
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25570684 0.96 ENPP3 (0.38) VSIRENPP3ENPP1TRPA1CSNK2A2
SCHEMBL25570433 0.95 ENPP3 (0.39) VSIRPTPN1ENPP3ENPP1TRPA1
SCHEMBL25570914 0.90 ALDH1A1 (0.36) ENPP3NPC1MAPTMEN1KMT2A
SCHEMBL25570719 0.90 ENPP3 (0.39) VSIRPTPN1ENPP3ENPP1TRPA1
SCHEMBL25570938 0.90 ENPP3 (0.39) VSIRPTPN1ENPP3ENPP1TRPA1
SCHEMBL25570913 0.89 ENPP3 (0.39) ENPP3NPC1MAPTMEN1KMT2A
SCHEMBL25570436 0.88 MAPT (0.41) ENPP3NPC1MAPTMEN1KMT2A
SCHEMBL25570688 0.88 MAPT (0.41) ENPP3NPC1MAPTMEN1KMT2A
SCHEMBL24523398 0.88 PRKCZ (0.36) NPC1MAPTMEN1KMT2AGAA
SCHEMBL24523399 0.88 PRKCZ (0.36) NPC1MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167097-A1 HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167097-A1 HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION KCNH1, MCM4, MCM2 VSIR 4651/4885PTPN1 3337/4885ENPP3 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.